Korsana Biosciences (KRSA) Stock Price, News & Analysis
What Changed
Price Move History
- Daily moves over 5%
- 14 33 sessions, September 9, 2026 to October 23, 2026
- Largest daily move
- +29.9% close of September 11, 2026
- 1-month change
- -3.1% closing prices, September 23, 2026 to October 23, 2026
Company Description
Korsana Biosciences (NASDAQ: KRSA) is classified in the biotechnology industry within the Healthcare sector and carries a market capitalization of $1.4B.
KRSA has declined 3.1% over the past month. The last closing price was $31.31.
For FY2025, Korsana Biosciences reported revenue of $2.1M with net income of -$3.5M and diluted earnings per share of -$1.11.
This page collects what Stock Titan holds for KRSA, including price data, latest news, SEC filings, financial highlights, upcoming events, and short interest trends.
Stock Performance
Korsana Biosciences (KRSA) closed at $31.31 on October 23, 2026. Over the past month, the price has lost 3.1%.
KRSA Metrics & Rankings
Price returns through October 23, 2026. Month-to-date and YTD include the first trading day. Ranking links may use different dates.
Latest News
Korsana Biosciences has 1 recent news article. Key topics include private placement, acquisition. View all KRSA news →
SEC Filings
Korsana Biosciences has filed 10 recent SEC filings, including 4 Form 144, 2 Form SCHEDULE 13G/A, 2 Form SCHEDULE 13G, 1 Form DEF 14A. The most recent filing was submitted on October 22, 2026. SEC filings provide transparency into a company's financial condition, material events, and regulatory compliance. View all KRSA SEC filings →
Financial Highlights
Korsana Biosciences generated $2.1M in revenue in FY2025, operating income reached -$5.0M, and net income was -$3.5M. Diluted earnings per share stood at -$1.11. The company generated -$3.3M in operating cash flow. The current ratio was 5.15, measuring current assets divided by current liabilities.
Upcoming Events
Phase 1 topline data
Interim PoC data
Korsana Biosciences has 2 upcoming scheduled events. The next event, "Phase 1 topline data", is scheduled for May 1, 2027 (in 188 days). Investors can track these dates to stay informed about potential catalysts that may affect the KRSA stock price.
Short Interest History
Short interest in Korsana Biosciences (KRSA) currently stands at 11.6 thousand shares, up 160.1% from the previous reporting period, representing 0.0% of the float. Since September 2026, short interest has increased by 160.1%.
Days to Cover History
Days to cover for Korsana Biosciences (KRSA) currently stands at 1.0 days. The ratio is the reported short interest divided by the average daily trading volume.
KRSA Company Profile & Sector Positioning
Korsana Biosciences (KRSA) operates in the Biotechnology industry within the broader Healthcare sector and is listed on the NASDAQ.